Update on risk factors and biomarkers of sudden unexplained cardiac death

Jiaqian Lou1, Huaiyao Chen2, Shuainan Huang3

  • 1Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai, 200063, PR China; Department of Forensic Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211166, PR China; Yangpu Branch of Shanghai Public Security Bureau, Shanghai, 200090, PR China.

Insights

Sudden unexplained cardiac death (SUCD) poses a forensic challenge due to lack of morphological evidence. Research highlights psychological stress and genetics as risk factors, with micro-RNAs and AI showing promise for diagnosis.

Area of Science:

  • Forensic Pathology
  • Cardiology
  • Molecular Biology

Background:

  • Sudden cardiac death (SCD) is a major global cause of mortality, often linked to structural heart disease.
  • Sudden unexplained cardiac death (SUCD) accounts for 1-15% of SCD cases and lacks clear postmortem pathological findings.
  • Diagnosing SUCD is challenging due to the absence of morphological evidence, especially in cases involving psychological stress or ion channelopathies.

Purpose of the Study:

  • To review updated risk factors for SUCD, including genetic predispositions and psychological stress.
  • To explore potential molecular biomarkers for the diagnosis and prediction of SUCD.
  • To discuss emerging research in novel diagnostic measurements for SUCD.

Main Methods:

  • Literature review of recent advancements in understanding SUCD.
  • Identification and summary of genetic and psychological risk factors.
  • Compilation of potential diagnostic biomarkers such as micro-RNAs, heat shock proteins, Galectin-3, and inflammation factors.

Main Results:

  • Psychological stress, exemplified by Takotsubo cardiomyopathy, and inherited ion channelopathies are significant contributors to SUCD.
  • Micro-RNAs, heat shock proteins, Galectin-3, and inflammation factors are identified as potential diagnostic biomarkers.
  • Novel approaches including chemical analysis, machine learning, and artificial intelligence are being investigated for SUCD prediction.

Conclusions:

  • SUCD diagnosis remains a significant challenge in forensic pathology due to the lack of observable evidence.
  • Identifying SUCD risk factors and reliable biomarkers is crucial for improving diagnosis and prediction.
  • Continued research into molecular biomarkers and advanced analytical techniques is essential for advancing SUCD understanding.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
382
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
244
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
163
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
53
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
100